APA (7th ed.) Citation

Fu, C., Ngo, D., Tinajero, J., Otoukesh, S., & Salhotra, A. (2025). Blinatumomab use in patients with CD19 positive B-ALL and hepatic dysfunction. Leukemia & Lymphoma, 66(2), 320. https://doi.org/10.1080/10428194.2024.2416018

Chicago Style (17th ed.) Citation

Fu, Cynthia, Dat Ngo, Jose Tinajero, Salman Otoukesh, and Amandeep Salhotra. "Blinatumomab Use in Patients with CD19 Positive B-ALL and Hepatic Dysfunction." Leukemia & Lymphoma 66, no. 2 (2025): 320. https://doi.org/10.1080/10428194.2024.2416018.

MLA (9th ed.) Citation

Fu, Cynthia, et al. "Blinatumomab Use in Patients with CD19 Positive B-ALL and Hepatic Dysfunction." Leukemia & Lymphoma, vol. 66, no. 2, 2025, p. 320, https://doi.org/10.1080/10428194.2024.2416018.